Centre For Eye Research Australia Limited

About

The Centre For Eye Research Australia (CERA) is an independent Medical Research Institute affiliated with the University of Melbourne and the Royal Victorian Eye and Ear Hospital. It is a world leader in eye research, dedicated to eliminating major eye diseases, preventing vision loss, and discovering cures to restore sight through advanced research and clinical trials.

Board Interlocks (6 shared directors)

Giving Philosophy

CERA's giving philosophy is centered on partnering with individuals, philanthropic trusts, foundations, industry, and government to secure funding for groundbreaking eye research. They aim to accelerate medical breakthroughs and achieve maximum impact for individuals experiencing vision impairment and blindness, often seeking multi-year grants to provide long-term security for their leading researchers.

Tips for Applicants

For potential philanthropic supporters, CERA encourages direct engagement with their Philanthropy & Fundraising Team to align donor interests with CERA's research expertise and maximize impact. They can facilitate bespoke family giving opportunities and manage sub-funds. Researchers interested in collaboration or employment should align with CERA's core research areas in eye disease prevention, diagnosis, and treatment.

Notable Grants

• A $10 million investment from Breakthrough Victoria for the establishment of Cerulea Clinical Trials (2023)
• NHMRC grants totaling over $1.3 million to Professor Robyn Guymer for age-related macular degeneration research (2016)
• A $1.92 million grant from the CUREator+ scheme to CERA spin-out company Mirugen for gene therapy research (2024)
• Various grants from the Macular Disease Foundation Australia to CERA researchers for macular disease research (2025)

Financial History (1 years)